Políticas de cobertura de farmacia

Resultados de la búsqueda

Fecha de vigenciaPolicy NameReviewed Date
1/24/2019 Drug Management Program-Opioid Program
11/21/2023
10/13/2023 Preferred Adalimumab Products
11/21/2023
11/15/2023 Akeega (niraparib and abiraterone acetate)
11/15/2023
1/1/2020 Antidepressant Agents
11/15/2023
1/1/2020 Aptiom® (eslicarbazepine acetate)
11/15/2023
12/11/2019 Asparlas™ (calaspargase pegol-mknl)
11/15/2023
1/1/2020 Braftovi™ (encorafenib) and Mektovi® (binimetinib)
11/15/2023
11/22/2023 Brixadi™ (buprenorphine)
11/15/2023
1/1/2024 Byooviz™ (ranibizumab-nuna)
11/15/2023
1/1/2020 Clindagel® (clindamycin phosphate gel)
11/15/2023
11/22/2023 Cosentyx (secukinumab) intravenous solution
11/15/2023
11/22/2023 Cosentyx (secukinumab) intravenous solution
11/15/2023
11/22/2023 Cosentyx (secukinumab) intravenous solution
11/15/2023
1/1/2021 Cotellic® (cobimetinib)
11/15/2023
1/1/2021 Cotellic® (cobimetinib)
11/15/2023
1/1/2023 Diacomit® (stiripentol)
11/15/2023
4/21/2021 Dupixent® (dupilumab) injection
11/15/2023
1/1/2022 Dupixent® (dupilumab) injection
11/15/2023
9/29/2008 Elaprase® (idursulfase)
11/15/2023
1/1/2020 Eligard® (leuprolide acetate)
11/15/2023
11/15/2023 Elrexfio (elranatamab-bcmm)
11/15/2023
1/1/2020 Emflaza® (deflazacort)
11/15/2023
11/22/2023 Entyvio® (vedolizumab)
11/15/2023
11/22/2023 Entyvio® (vedolizumab)
11/15/2023
11/22/2023 Entyvio® (vedolizumab)
11/15/2023
7/20/2017 FEIBA NF (Anti-Inhibitor Coagulant Complex)
11/15/2023
1/1/2020 Firdapse® (amifampridine)
11/15/2023
1/1/2020 Firmagon® (degarelix)
11/15/2023
12/28/2022 Furoscix® (furosemide)
11/15/2023
1/1/2019 Gattex® (teduglutide)
11/15/2023
1/20/2021 Gimoti™ (metoclopramide)
11/15/2023
3/18/2020 Givlaari® (givosiran)
11/15/2023
12/9/2020 Hemady™ (dexamethasone tablet)
11/15/2023
1/1/2016 Intuniv® (guanfacine extended-release tablets)
11/15/2023
1/1/2020 Jevtana® (cabazitaxel)
11/15/2023
1/20/2016 Kanuma® (sebelipase alfa)
11/15/2023
1/1/2016 Kapvay® (clonidine extended-release)
11/15/2023
1/1/2023 Keytruda (pembrolizumab)
11/15/2023
1/1/2020 Lamotrigine Products
11/15/2023
1/1/2017 Leuprolide acetate
11/15/2023
12/12/2018 Lexette® (halobetasol) Topical Foam
11/15/2023
1/1/2011 Lumizyme® (alglucosidase alpha)
11/15/2023
1/1/2020 Lupron® (leuprolide acetate) and Generic Depot Products
11/15/2023
1/1/2024 Lybalvi (olanzapine and samidorphan)
11/15/2023
1/1/2020 Molindone hydrochloride
11/15/2023
11/22/2023 Motpoly XR (lacosamide extended release)
11/15/2023
1/1/2020 NSAID Combination Products
11/15/2023
11/22/2023 Non-Preferred Adalimumab Products
11/15/2023
11/22/2023 Non-Preferred Adalimumab Products
11/15/2023
1/20/2017 NovoSeven® RT (Coagulation Factor VIIa [Recombinant])
11/15/2023
11/1/2006 Noxafil® (posaconazole)
11/15/2023
1/1/2021 Nplate® (romiplostim)
11/15/2023
1/20/2017 Obizur [antihemophilic (recombinant), porcine sequence]
11/15/2023
1/1/2023 Opdivo (nivolumab)
11/15/2023
1/1/2020 Ophthalmic Antibiotics
11/15/2023
1/1/2020 Ophthalmic Non-Steroidal Anti-Inflammatory Drugs
11/15/2023
1/1/2020 Ophthalmic Steroids
11/15/2023
1/1/2020 Ophthalmic Steroids
11/15/2023
6/19/2019 Orphenadrine Products
11/15/2023
1/1/2020 Oxaydo® (oxycodone HCL)
11/15/2023
4/21/2021 Oxlumo® (lumasiran)
11/15/2023
1/1/2020 Oxtellar XR® (oxcarbazepine extended release)
11/15/2023
1/1/2023 Pediatric Cardiovascular Products
11/15/2023
11/30/2022 Pedmark ® (sodium thiosulfate injection)
11/15/2023
6/6/2013 Procysbi® (cysteamine)
11/15/2023
1/1/2018 Rapid-Acting Fentanyl Products
11/15/2023
1/1/2024 Rexulti (brexpiprazole)
11/15/2023
10/14/2020 Rhopressa® (netarsudil), Rocklatan® (netarsudil and latanoprost)
11/15/2023
1/1/2024 Rinvoq (upadacitinib)
11/15/2023
1/1/2020 Rozerem (ramelteon)
11/15/2023
11/22/2023 Rystiggo (rozanolixizumab-noli)
11/15/2023
12/15/2021 Saphnelo™ (anifrolumab-fnia)
11/15/2023
3/21/2018 Sinuva™ (mometasone furoate) sinus implant
11/15/2023
5/2/2013 Sirturo® (bedaquiline)
11/15/2023
2/21/2018 Solosec™ (secnidazole)
11/15/2023
11/23/2022 Spevigo® (spesolimab-sbzo)
11/15/2023
1/1/2020 Sprix® (ketorolac tromethamine) nasal spray
11/15/2023
1/1/2020 Sublocade™ (buprenorphine extended-release) injection
11/15/2023
11/22/2023 Talvey (talquetamab)
11/15/2023
1/1/2018 Thrombate III® [Antithrombin III (Human)]
11/15/2023
1/1/2018 Topical Doxepin Products (doxepin, Prudoxin®, Zonalon®)
11/15/2023
1/1/2023 Topical Vitamin D Products
11/15/2023
5/16/2018 Trogarzo™ (ibalizumab-uiyk)
11/15/2023
5/25/2022 Vabysmo™ (faricimab-svoa)
11/15/2023
1/1/2023 Vabysmo™ (faricimab-svoa)
11/15/2023
1/1/2020 Visudyne® (verteporfin)
11/15/2023
11/30/2022 Vivjoa™ (oteseconazole)
11/15/2023
11/22/2023 Xdemvy™ (lotilaner)
11/15/2023
11/30/2022 Xenpozyme™ (olipudase alfa) intravenous solution
11/15/2023
2/23/2022 Xipere™ (triamcinolone acetonide)
11/15/2023
4/20/2016 Xuriden® (uridine triacetate)
11/15/2023
11/22/2023 Ycanth™ (cantharidin)
11/15/2023
1/1/2020 ZTlido® (lidocaine topical system)
11/15/2023
10/16/2019 Zelnorm™ (tegaserod)
11/15/2023
1/1/2017 Zoladex® (goserelin)
11/15/2023
11/23/2022 Zoryve® (roflumilast) cream
11/15/2023
1/1/2016 Zyclara® (imiquimod)
11/15/2023
5/1/2021 Zypitamag® (pitavastatin)
11/15/2023
1/1/2021 Zypitamag™ (pitavastatin)
11/15/2023
1/1/2019 Non-Formulary Exceptions
11/2/2023
11/8/2023 Ojjaara (momelotinib)
11/2/2023
11/1/2019 Rozlytrek™ (entrectinib)
11/2/2023
10/25/2023 AIRSUPRA (albuterol and budesonide) inhalation aerosol
10/18/2023
12/9/2020 Alkindi® (hydrocortisone) sprinkle capsule
10/18/2023
1/1/2019 Allergy Ophthalmics
10/18/2023
1/1/2020 Ampyra® (dalfampridine)
10/18/2023
1/1/2019 Azopt® (brinzolamide ophthalmic suspension) 1%
10/18/2023
2/23/2022 Brimonidine-timolol eye drops (generic Combigan)
10/18/2023
1/1/2022 Bupropion Containing Products (Aplenzin®, Forfivo® XL)
10/18/2023
10/26/2022 Camzyos™ (mavacamten)
10/18/2023
1/1/2024 Caplyta (lumateperone)
10/18/2023
4/28/2011 Caprelsa® (vandetanib)
10/18/2023
1/1/2020 Carbinoxamine 6mg tablet
10/18/2023
1/1/2015 Chenodal™ (chenodiol)
10/18/2023
5/9/2013 Cysteamine Ophthalmic Products (Cystaran™, Cystadrops®)
10/18/2023
2/17/2021 Danyelza® (naxitamab-gqgk)
10/18/2023
1/1/2023 Deferasirox Products
10/18/2023
1/1/2023 Deferasirox Tablet
10/18/2023
1/1/2024 Deferasirox products
10/18/2023
1/1/2022 Defitelio® (defibrotide sodium)
10/18/2023
1/1/2021 Duexis® (ibuprofen-famotidine) tablet
10/18/2023
10/16/2019 Duloxetine Containing Products
10/18/2023
1/1/2018 Effient® (prasugrel)
10/18/2023
9/27/2023 Elevidys (delandistrogene moxeparvovec-rokl)
10/18/2023
1/1/2023 Epoetin Alfa (Epogen, Procrit, Retacrit)
10/18/2023
12/15/2021 Eprontia™ (topiramate) oral solution
10/18/2023
2/9/2012 Erivedge® (vismodegib)
10/18/2023
11/11/2020 Evrysdi® (risdiplam)
10/18/2023
1/1/2024 Ferriprox® (deferiprone)
10/18/2023
1/1/2022 Fetzima® (levomilnacipran)
10/18/2023
2/23/2022 Fyarro (sirolimus protein-bound particles for injectable suspension)
10/18/2023
1/1/2020 Gralise® (gabapentin)
10/18/2023
10/15/2015 Keveyis® (dichlorphenamide)
10/18/2023
1/1/2020 Lidocaine 5% topical ointment
10/18/2023
10/8/2021 Long Acting Insulins
10/18/2023
1/1/2020 Lonsurf® (trifluridine and tipiracil)
10/18/2023
1/1/2023 Lynparza (olaparib)
10/18/2023
1/1/2016 Megace® ES (megestrol acetate)
10/18/2023
11/23/2022 Methocarbamol tablet
10/18/2023
1/1/2022 Mircera® (methoxy polyethylene glycol-epoetin beta)
10/18/2023
10/26/2022 Nexiclon™ XR (clonidine ER) tablet
10/18/2023
1/1/2024 Non-Preferred Continuous Glucose Monitoring Systems
10/18/2023
10/29/2015 Odomzo® (sonidegib)
10/18/2023
1/1/2020 Ophthalmic Antibiotics
10/18/2023
1/1/2020 Ophthalmic Non-Steroidal Anti-Inflammatory Drugs
10/18/2023
3/6/2019 Oxandrin® (oxandrolone)
10/18/2023
1/1/2016 Oxandrolone
10/18/2023
1/1/2016 Pancreatic Enzymes
10/18/2023
1/1/2020 Pancreatic Enzymes
10/18/2023
6/3/2020 Pemazyre™ (pemigatinib)
10/18/2023
1/1/2024 Preferred Continuous Glucose Monitoring Systems
10/18/2023
1/1/2020 Previous Treatment/Prior Therapy/Trial
10/18/2023
9/21/2016 Probuphine® (buprenorphine) Implant
10/18/2023
1/1/2020 Qudexy XR®, Trokendi XR® (topiramate)
10/18/2023
7/8/2020 Retevmo™ (selpercatinib)
10/18/2023
5/16/2018 Rhopressa® (netarsudil)
10/18/2023
1/1/2019 Savella® (milnacipran)
10/18/2023
2/20/2019 Short Acting Beta Agonists
10/18/2023
5/22/2014 Sitavig® (acyclovir)
10/18/2023
1/1/2020 Spritam® (levetiracetam)
10/18/2023
1/1/2020 Stem cell mobilizing agents (Mozobil, Aphexda, Plerixafor)
10/18/2023
1/1/2022 Synagis® (palivizumab)
10/18/2023
11/21/2012 Synribo® (omacetaxine mepesuccinate)
10/18/2023
1/1/2022 Tobramycin for Inhalation
10/18/2023
1/1/2024 Tobramycin for Inhalation
10/18/2023
1/16/2019 Tolsura (itraconazole)
10/18/2023
1/1/2021 Topical Psoriasis Agents
10/18/2023
1/1/2023 Topical Psoriasis Agents
10/18/2023
1/1/2022 Trintellix (vortioxetine)
10/18/2023
1/1/2009 VFEND® (voriconazole)
10/18/2023
10/18/2023 Vanflyta (quizartinib)
10/18/2023
10/25/2023 Vowst (fecal microbiota spores, live-brpk)
10/18/2023
1/1/2024 Vraylar (cariprazine)
10/18/2023
7/19/2017 Xadago® (safinamide)
10/18/2023
5/20/2020 Xcopri® (cenobamate)
10/18/2023
1/1/2021 ZTlido™ (lidocaine topical system)
10/18/2023
8/5/2010 Zuplenz® (ondansetron oral soluble film)
10/18/2023
6/19/2019 Medical Necessity Determinations
10/12/2023
12/1/2022 Medical Necessity Determinations
10/12/2023
1/1/2023 Medical Necessity Determinations
10/12/2023
1/1/2022 Opioid Days' Supply Limitation
10/12/2023
1/1/2019 Opioid Days' Supply Limitation
10/12/2023
11/3/2021 Opioid Days' Supply Limitation - Florida Statute 456.44(5)(a) Prescription Supply Limits
10/12/2023
2/1/2021 Opioid Utilization Program - Concurrent Use of Opioids and Benzodiazepines (COB) edits
10/12/2023
1/1/2024 Stivarga (regorafenib)
10/12/2023
1/1/2023 Stivarga (regorafenib)
10/12/2023
1/1/2023 Aflibercept Products (Eylea®, Eylea® HD)
10/5/2023
1/1/2022 Aflibercept Products (Eylea®, Eylea® HD)
10/5/2023
1/1/2024 ADHD Long Acting Stimulants
9/20/2023
1/1/2022 ADHD Long Acting Stimulants
9/20/2023
1/1/2019 Actemra® (tocilizumab) Intravenous
9/20/2023
1/1/2019 Actemra® (tocilizumab) Intravenous
9/20/2023
1/1/2022 Actemra® (tocilizumab) Subcutaneous
9/20/2023
1/1/2022 Actemra® (tocilizumab) Subcutaneous
9/20/2023
1/1/2020 Actemra® IV (tocilizumab)
9/20/2023
1/1/2024 Afinitor/Afinitor Disperz (everolimus)
9/20/2023
1/1/2013 Aldurazyme® (laronidase)
9/20/2023
1/1/2016 Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®)
9/20/2023
1/1/2023 Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Zemaira®)
9/20/2023
1/1/2024 Alpha-1 Proteinase Inhibitors (Prolastin-C®, Zemaira®)
9/20/2023
1/1/2016 Alpha-1 Proteinase Inhibitors (Prolastin-C®, Zemaira®)
9/20/2023
1/1/2024 Alphagan® P (brimonidine)
9/20/2023
9/28/2022 Amvuttra™ (vutrisiran)
9/20/2023
1/1/2023 Avsola® (infliximab-axxq)
9/20/2023
6/17/2020 Avsola® (infliximab-axxq)
9/20/2023
1/1/2022 Avsola™ (infliximab-axxq)
9/20/2023
1/1/2024 Azopt® (brinzolamide ophthalmic suspension) 1%
9/20/2023
1/1/2024 Beovu® (brolucizumab)
9/20/2023
1/1/2021 Cabometyx™ (cabozantinib)
9/20/2023
1/1/2023 Cholbam® (cholic acid)
9/20/2023
1/1/2020 Cimzia (certolizumab pegol)
9/20/2023
1/1/2022 Cimzia® (certolizumab pegol)
9/20/2023
1/1/2022 Cimzia® (certolizumab pegol)
9/20/2023
9/27/2023 Columvi™ (glofitamab-gxbm)
9/20/2023
11/11/2020 Conjupri® (levamlodipine)
9/20/2023
1/1/2006 Medicamentos para tos y resfríos
9/20/2023
1/1/2024 Daxxify® (daxibotulinumtoxinA-lanm)
9/20/2023
10/1/2023 Daxxify® (daxibotulinumtoxinA-lanm)
9/20/2023
1/1/2017 Diabetic Test Strips and Meters
9/20/2023
1/1/2022 Dihydroergotamine Products
9/20/2023
1/1/2023 Enhertu (fam-trastuzumab deruxtecan-nxki)
9/20/2023
1/20/2021 Enspryng™ (satralizumab-mwge)
9/20/2023
11/17/2021 Exkivity (mobocertinib)
9/20/2023
1/1/2023 Finacea® (azelaic acid) topical foam
9/20/2023
11/11/2020 Gavreto™ (pralsetinib)
9/20/2023
1/1/2021 Growth Hormone (Hormona del crecimiento)
9/20/2023
1/1/2022 Growth Hormone (Hormona del crecimiento)
9/20/2023
9/28/2022 Hyftor™ (sirolimus topical gel)
9/20/2023
1/1/2024 Ibsrela® (tenapanor)
9/20/2023
11/22/2023 Ilumya® (tildrakizumab)
9/20/2023
11/22/2023 Ilumya® (tildrakizumab)
9/20/2023
11/22/2023 Ilumya™ (tildrakizumab)
9/20/2023
1/1/2023 Inflectra ® (infliximab-dyyb)
9/20/2023
1/1/2019 Inflectra® (infliximab-dyyb)
9/20/2023
1/1/2022 Infliximab intravenous solution
9/20/2023
1/1/2022 Ingrezza® (valbenazine)
9/20/2023
9/28/2022 Inhaled Corticosteroid and Long Acting Beta Agonists
9/20/2023
1/1/2024 Intranasal Rhinitis Agents
9/20/2023
1/1/2023 Intranasal Rhinitis Agents
9/20/2023
1/1/2024 Intravenous Iron Products
9/20/2023
9/27/2023 Izervay™ (avacincaptad pegol)
9/20/2023
1/1/2020 Jakafi® (ruxolitinib)
9/20/2023
8/1/2021 Jemperli (dostarlimab-gxly)
9/20/2023
1/1/2023 Jemperli (dostarlimab-gxly)
9/20/2023
9/27/2023 Joenja® (leniolisib)
9/20/2023
11/17/2021 Kerendia® (finerenone)
9/20/2023
11/17/2021 Kerendia® (finerenone)
9/20/2023
1/1/2022 Kineret® (anakinra)
9/20/2023
1/1/2022 Kineret® (anakinra)
9/20/2023
8/23/2023 Leqembi™ (lecanemab-irmb)
9/20/2023
1/1/2023 Levoleucovorin products (Fusilev, Khapzory)
9/20/2023
9/27/2023 Litfulo™ (ritlecitinib)
9/20/2023
1/1/2024 Long Acting Opioids
9/20/2023
1/1/2024 Mavenclad® (cladribine)
9/20/2023
1/1/2023 Mavenclad® (cladribine)
9/20/2023
1/1/2023 Nebivolol (generic Bystolic)
9/20/2023
10/20/2021 Nexviazyme™ (avalglucosidase alfa-ngpt) Injection
9/20/2023
10/13/2023 Non-Preferred Adalimumab Products
9/20/2023
1/1/2023 Non-Preferred GLP Analogs
9/20/2023
1/1/2024 Non-Preferred Infliximab Products - Renflexis (infliximab-abda), Avsola (infliximab-axxq)
9/20/2023
1/1/2024 Non-Preferred Infliximab products - Renflexis (infliximab-abda) and Avsola (infliximab-axxq)
9/20/2023
1/1/2023 Non-Preferred Multiple Sclerosis Interferons
9/20/2023
1/1/2023 Non-Preferred Oral Multiple Sclerosis Products
9/20/2023
1/1/2023 Non-Preferred SGLT2
9/20/2023
1/1/2023 Non-Preferred Filgrastim Products - Neupogen (filgrastim) and Releuko (filgrastim-ayow)
9/20/2023
1/1/2023 Non-preferred Pegfilgrastim Products - Fylnetra (pegfilgrastim-pbbk), Neulasta (pegfilgrastim), Nyvepria (pegfilgrastim-apfg), Stimufend (pegfilgrastim-fpgk) and Ziextenzo (pegfilgrastim-bmez)
9/20/2023
1/1/2023 Non-preferred Pegfilgrastim Products - Fylnetra (pegfilgrastim-pbbk), Nyvepria (pegfilgrastim-apfg), Stimufend (pegfilgrastim-fpgk) and Ziextenzo (pegfilgrastim- bmez)
9/20/2023
1/1/2024 Nonsteroidal Anti-Inflammatory Drug Products
9/20/2023
1/1/2023 Ocaliva® (obeticholic acid)
9/20/2023
1/1/2023 Ocrevus® (ocrelizumab)
9/20/2023
7/1/2022 Olumiant® (baricitinib)
9/20/2023
7/1/2022 Olumiant® (baricitinib)
9/20/2023
12/9/2020 Ongentys® (opicapone)
9/20/2023
1/20/2016 Onivyde ® (liposomal irinotecan)
9/20/2023
11/11/2020 Onureg™ (azacitidine)
9/20/2023
1/1/2024 Ophthalmic Antibiotics
9/20/2023
1/1/2024 Ophthalmic Beta Blockers
9/20/2023
1/26/2022 Opzelura™ (ruxolitinib)
9/20/2023
1/1/2020 Orencia® (abatacept) Intraveneous
9/20/2023
1/1/2022 Orencia® (abatacept) Intraveneous
9/20/2023
1/1/2019 Orencia® (abatacept) Intravenous
9/20/2023
1/1/2022 Orencia® (abatacept) Subcutaneous
9/20/2023
1/1/2022 Orencia® (abatacept) Subcutaneous
9/20/2023
1/1/2023 Otezla® (apremilast)
9/20/2023
1/1/2022 Pomalyst® (pomalidomide)
9/20/2023
10/13/2023 Preferred Adalimumab Products
9/20/2023
10/13/2023 Preferred Adalimumab Products
9/20/2023
1/1/2024 Preferred Infliximab Products - Inflectra (infliximab-dyyb)
9/20/2023
1/1/2024 Preferred Infliximab Products - Remicade (infliximab), Inflectra (infliximab-dyyb), and infliximab
9/20/2023
1/1/2022 Preferred Multiple Sclerosis Products
9/20/2023
1/1/2023 Preferred Filgrastim Products - Nivestym (filgrastim-aafi) and Zarxio (filgrastim-sndz)
9/20/2023
1/1/2023 Preferred Pegfilgrastim Products -  Neulasta (pegfilgrastim), Fulphila (pegfilgrastim-jmdb), and Udenyca (pegfilgrastim-cbqv)
9/20/2023
1/1/2023 Preferred Pegfilgrastim Products - Fulphila (pegfilgrastim-jmdb) and Udenyca (pegfilgrastim- cbqv)
9/20/2023
2/21/2018 Prevymis™ (letermovir)
9/20/2023
1/1/2023 Prolastin-C® (alpha-1 proteinase inhibitor)
9/20/2023
1/1/2023 Pyrukynd® (mitapivat)
9/20/2023
12/19/2018 Qbrexza® (glycopyrronium)
9/20/2023
1/20/2021 Qdolo™ (tramadol) oral solution
9/20/2023
1/1/2024 Qelbree (viloxazine)
9/20/2023
5/19/2021 Qelbree™ (viloxazine)
9/20/2023
1/1/2024 Quviviq (daridorexant)
9/20/2023
1/1/2021 Regranex® (becaplermin)
9/20/2023
1/1/2020 Remicade® (infliximab)
9/20/2023
1/1/2019 Remicade® (infliximab)
9/20/2023
1/1/2020 Renflexis (infliximab-abda)
9/20/2023
1/1/2022 Renflexis® (infliximab-abda)
9/20/2023
1/1/2023 Renflexis® (infliximab-abda)
9/20/2023
1/1/2023 Revlimid (lenalidomida)
9/20/2023
10/8/2021 Rezurock (belumosudil)
9/20/2023
1/1/2023 Rinvoq® (upadacitinib)
9/20/2023
1/1/2024 Rocklatan® (netarsudil and latanoprost)
9/20/2023
1/1/2024 Sandostatin® S.C., Sandostatin LAR® Depot (octreotide acetate for injection)
9/20/2023
1/22/2015 Savaysa® (edoxaban)
9/20/2023
1/1/2023 Signifor® LAR (pasireotide)
9/20/2023
1/1/2022 Siliq® (brodalumab) injection
9/20/2023
1/1/2022 Siliq® (brodalumab) injection
9/20/2023
1/1/2024 Simbrinza™ (brinzolamide/brimonidine ophthalmic suspension)
9/20/2023
1/1/2019 Simponi ARIA (golimumab)
9/20/2023
1/1/2022 Simponi® (golimumab)
9/20/2023
1/1/2022 Simponi® (golimumab)
9/20/2023
2/22/2023 Sotyktu (deucravacitinib)
9/20/2023
2/22/2023 Sotyktu (deucravacitinib)
9/20/2023
1/1/2024 Spiriva Handihaler® (tiotropium bromide) ETB
9/20/2023
1/1/2022 Stelara® (ustekinumab)
9/20/2023
1/1/2024 Susvimo™ (ranibizumab)
9/20/2023
1/1/2021 Tadalafil Products - PAH Indication Only
9/20/2023
1/1/2022 Taltz® (ixekizumab)
9/20/2023
1/1/2022 Taltz® (ixekizumab)
9/20/2023
12/12/2018 Tegsedi® (inotersen)
9/20/2023
7/15/2020 Thalomid® (thalidomide)
9/20/2023
1/1/2024 Tivdak (tisotumab vedotin-tftv)
9/20/2023
1/1/2024 Torisel (temsirolimus)
9/20/2023
1/1/2019 Torisel® (temsirolimus)
9/20/2023
1/1/2022 Tremfya® (guselkumab)
9/20/2023
1/1/2024 Triptans
9/20/2023
10/21/2021 Trudhesa™ (dihydroergotamine mesylate)
9/20/2023
1/1/2024